Literature DB >> 14512002

The value of screening in siblings of patients with abdominal aortic aneurysm.

G Frydman1, P J Walker, K Summers, M West, D Xu, T Lightfoot, C Codd, T Dique, M Nataatmadja.   

Abstract

OBJECTIVES: This study aimed to determine the incidence of abdominal aortic aneurysm (AAA) in a large group of siblings of Australian AAA patients to determine if screening in this group is justified.
METHODS: 1254 siblings of 400 index AAA patients were identified and offered aortic ultrasound screening. An age and sex matched control group was recruited from patients having abdominal CT scans for non-vascular indications. AAA was defined by an infrarenal aortic diameter of > or =3 cm or a ratio of the infrarenal to suprarenal aortic diameter of > or =2.0. A ratio of 1.0-1.5 was considered normal, and a ratio of >1.5 to <2.0 was considered ectatic. Aortic enlargement was defined as ectasia or aneurysm.
RESULTS: 276 (22%) siblings could be contacted and agreed to screening or had previously been diagnosed with AAA. All 118 controls had normal diameter aortas. 55/276 siblings had previously been diagnosed with AAA. The remaining 221 siblings underwent ultrasound screening. Overall, 30% (84/276) had enlarged aortas (5% ectasia, 25% aneurysmal); 43% of male siblings (64/150) and 16% of females siblings (20/126). The incidence was 45% in brothers of female index patients, 42% in brothers of male patients, 23% in sisters of female patients, and 14% in sisters of male index patients.
CONCLUSIONS: The overall incidence of aortic enlargement of 30% found in this study warrants a targeted screening approach with ultrasound for all siblings of patients with AAA. A similar targeted approach for screening of the children of AAA patients would also seem advisable.

Entities:  

Mesh:

Year:  2003        PMID: 14512002     DOI: 10.1016/s1078-5884(03)00316-2

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  6 in total

Review 1.  Pathophysiology and epidemiology of abdominal aortic aneurysms.

Authors:  Ian M Nordon; Robert J Hinchliffe; Ian M Loftus; Matt M Thompson
Journal:  Nat Rev Cardiol       Date:  2010-11-16       Impact factor: 32.419

Review 2.  Pathology, natural history and treatment of abdominal aortic aneurysms.

Authors:  A R Zankl; H Schumacher; U Krumsdorf; H A Katus; L Jahn; C P Tiefenbacher
Journal:  Clin Res Cardiol       Date:  2006-12-22       Impact factor: 5.460

3.  Family members of patients with abdominal aortic aneurysms are at increased risk for aneurysms: analysis of 618 probands and their families from the Liège AAA Family Study.

Authors:  Natzi Sakalihasan; Jean-Olivier Defraigne; Marie-Ange Kerstenne; Jean-Paul Cheramy-Bien; Diane T Smelser; Gerard Tromp; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2013-12-21       Impact factor: 1.466

4.  Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture.

Authors:  Victoria L King; Alexander Y Lin; Fjoralba Kristo; Thomas J T Anderson; Neil Ahluwalia; Gregory J Hardy; A Phillip Owens; Deborah A Howatt; Dongxiao Shen; Andrew M Tager; Andrew D Luster; Alan Daugherty; Robert E Gerszten
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

Review 5.  Large animal models of cardiovascular disease.

Authors:  H G Tsang; N A Rashdan; C B A Whitelaw; B M Corcoran; K M Summers; V E MacRae
Journal:  Cell Biochem Funct       Date:  2016-02-24       Impact factor: 3.685

Review 6.  Dilating Vascular Diseases: Pathophysiology and Clinical Aspects.

Authors:  Ertan Yetkin; Selcuk Ozturk
Journal:  Int J Vasc Med       Date:  2018-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.